Background Implantable cardioverter-defibrillator (ICD) shocks are associated with
increased anxiety, health care utilization, and potentially mortality. Objective The purpose of …

Background Shock‐reduction implantable cardioverter‐defibrillator programming (SRP) was
associated with fewer therapies and improved survival in randomized controlled trials, but …

Objectives: Our purpose was to demonstrate that strategically chosen implantable
cardioverter-defibrillator (ICD) ventricular tachycardia (VT) or ventricular fibrillation (VF) …

Methods: The EMPIRIC trial was a worldwide, randomized comparison of standardized
versus physician tailored VT/VF programming in a broad group of dual chamber ICD …

Aims Strategically chosen ventricular tachycardia (VT)/ventricular fibrillation (VF) detection
and therapy parameters aimed at reducing shock deliveries were proven effective in studies …

Aims Shock therapy delivery by implantable cardioverter–defibrillators (ICD) can be painful
and may have negative psychological consequences. Reducing shock burden for patients …

Background Advances in medical treatment and outcomes in implantable cardioverter-
defibrillator (ICD) recipients incentivize a need for improved candidate selection and …

Objectives: The purpose of this randomized study was to determine whether a strategically
chosen standardized set of programmable settings is at least as effective as physician …

Background Inappropriate therapy is a common adverse effect in patients with an
implantable cardioverter–defibrillator (ICD) that may be prevented by appropriate …

Background Recent evidence has revealed the utility of prolonged arrhythmia detection
duration and increased rate cutoff to reduce implantable cardioverter-defibrillator (ICD) …